


Anti-SOS1 Recombinant Antibody Products

Anti-SOS1 Products
-
- Species Reactivity: Human
- Application: ELISA, WB
-
- Derivation: Phage display library screening
- Species Reactivity: Mouse, Rat, Human
- Type: IgG
- Application: WB, IHC-P, ICC/IF
- Anti-SOS1 Immunohistochemistry Kit (VS-0325-XY2147)
-
- Species Reactivity: Human, Mouse, Rat
- Target: SOS1
- Application: IHC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs proudly delivers an advanced portfolio of anti-SOS1 recombinant antibody products, meticulously developed to support and enhance the endeavors of researchers and pharmaceutical enterprises globally. These high-quality antibodies are characterized by their unparalleled specificity and robust affinity, thereby constituting indispensable reagents for the advancement of drug discovery initiatives and the development of therapeutic interventions targeting critical disease pathways.
SOS1: A Critical Target for Cancer Therapy
Son of Sevenless homolog 1 (SOS1) is a crucial guanine nucleotide exchange factor (GEF) that plays a pivotal role in activating the RAS-MAPK signaling pathway, a central regulator of cell growth, differentiation, and survival. Extensive research highlights SOS1's involvement in numerous human cancers, where its aberrant activity drives oncogenic signaling. Consequently, targeting SOS1 has emerged as a compelling strategy for developing novel anti-cancer therapies, offering a promising avenue to disrupt tumor progression and overcome drug resistance.
Alternative Names
Son of sevenless homolog 1; GF1; GGF1; GINGF; HGF; NS4; SOS Ras/Rac guanine nucleotide exchange factor 1; SOS-1.
Background
The SOS1 gene is an oncogene discovered in 2002 and is one of the HCF pathogenic genes that have been successfully cloned and identified. The SOS1 gene is located in the short arm 21 regions of chromosome 2 and plays an oncogene role in tumor cells. Domestic studies have shown that this gene is positively correlated with gingival fibromatosis and myocardial disease. Foreign studies have shown that SOS1 is positively correlated with the malignant degree of glioma and the proliferation of tumor cells. The role of SOS1 in carcinoid genes in tumor cells has attracted more and more attention. SOS1 can interact with MAPK pathway to introduce exogenous genes into the nucleus to regulate cell proliferation. With knockout of SOS1 gene or inhibition of SOS1 gene expression, it can be found that the proliferation of tumor cells is inhibited, and even the apoptosis of tumor cells is caused. SOS1 also interacts with a variety of genes, which are key to the regulation of tumor growth by other genes, but few have found a complete chain of action from the initiating factor to the eventual abnormal proliferation of the tumor. SOS2 is adjacent to the SOS1 locus. The positional structure determines the function, so SOS2 plays an oncogene function similar to SOS1 in tumors and inhibits the proliferation of tumor cells as long as the expression of SOS1/SOS2 is inhibited.
Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, RAS pathway related proteins
Intracellular
Cell type enhanced (Excitatory neurons, Inhibitory neurons, Oligodendrocyte precursor cells, Microglial cells)
Low immune cell specificity
Cell line enhanced (HMC-1)
Interacts (via C-terminus) with GRB2 (via SH3 domain) (PubMed:8493579, PubMed:7664271). Forms a complex with phosphorylated MUC1 and GRB2 (via its SH3 domains) (PubMed:7664271). Interacts with phosphorylated LAT2 (PubMed:12486104). Interacts with NCK1 and NCK2 (PubMed:10026169). Part of a complex consisting of ABI1, EPS8 and SOS1 (By similarity). Interacts (Ser-1134 and Ser-1161 phosphorylated form) with YWHAB and YWHAE (PubMed:22827337).
Guanine-nucleotide releasing factor
Anti-SOS1 rAb Products
At Creative Biolabs, our recombinant anti-SOS1 antibody products are engineered with superior precision, offering exceptional specificity and high affinity for the SOS1 protein. Produced through advanced recombinant technology, these antibodies ensure lot-to-lot consistency and minimal batch variation, critical for reliable and reproducible research outcomes. Their strong performance makes them suitable for a broad range of applications, including fundamental research and preclinical drug development.
Table 1. Featured anti-SOS1 recombinant antibody products at Creative Biolabs.
Cat. No. | Product Name | Target Species | Host Species | Applications |
MOB-1902CT | Recombinant Mouse anti-Human SOS1 Monoclonal antibody (TPT-2) | Human | Mouse | ELISA, WB |
MOR-3372 | Hi-Affi™ Recombinant Rabbit Anti-SOS1 Monoclonal Antibody (DS3372AB) | Mouse, Rat, Human | Rabbit IgG | WB, IHC-P, ICC/IF |
Creative Quality Control
Creative Biolabs employs stringent quality control measures to guarantee the highest standards for our anti-SOS1 recombinant antibodies. Each batch undergoes rigorous validation, including comprehensive binding assays, functional analyses, and purity assessments. This careful attention to detail guarantees high performance, repeatability, and dependability, giving researchers confidence in their experimental findings.
Customer Reviews

Recombinant Mouse anti-Human SOS1 Monoclonal antibody (TPT-2) (MOB-1902CT)

Hi-Affi™ Recombinant Rabbit Anti-SOS1 Monoclonal Antibody (DS3372AB) (MOR-3372)

Recombinant Mouse anti-Human SOS1 Monoclonal antibody (TPT-2) (MOB-1902CT)
rAb Production
Our anti-SOS1 recombinant antibodies are produced using state-of-the-art mammalian expression systems, ensuring optimal post-translational modifications and biological activity. This advanced production platform allows for large-scale manufacturing while maintaining exceptional purity and structural integrity, meeting the demands of both research and industrial applications.
Featured Anti-SOS1 Recombinant Antibody Production Platforms
Fig.1 Milligram-scale anti-SOS1 recombinant antibody production.
Fig.2 Gram-scale anti-SOS1 recombinant antibody production.
rAb Modalities
These versatile anti-SOS1 recombinant antibodies are available in multiple modalities, including various isotype formats and conjugation options, providing flexibility for diverse experimental designs.
Fig.3 Full-length anti-SOS1 recombinant antibody production and modalities.
SOS1-Targeted Drug Information
Table 2. Public drug targeting SOS1.
Company | Research phase | Classification | Condition |
BioTheryX (Originator) | Preclinical | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
Qingdao Putaike Biomedical Technology (Originator) | Preclinical |
Oligopeptides, less than 10 AA PROTACs (Proteolysis Targeting Chimeras) |
Cancer |
Hangzhou Advanced Research Institute UCAS (Originator) Nanjing University of Chinese Medicine (Originator) Shanghai Institute of Materia Medica (Originator) University of Chinese Academy Sciences (Originator) University of Minnesota (Originator) |
Preclinical |
Oligopeptides, less than 10 AA PROTACs (Proteolysis Targeting Chimeras) |
Cancer |
Suzhou Zelgen Biosciences (Originator) | Preclinical | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
Shanghai Institute of Materia Medica (Originator) | Preclinical | PROTACs (Proteolysis Targeting Chimeras) | Cancer, lung |
Shanghai Zelgen Medical Technology (Originator) Suzhou Zelgen Biosciences (Originator) |
Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
Nanjing University of Chinese Medicine (Originator) Shanghai Institute of Materia Medica (Originator) ShanghaiTech University (Originator) University of Chinese Academy Sciences (Originator) |
Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
Sichuan Huiyu Pharmaceutical (Originator) Sichuan Huiyu Seacross Pharma Technology (Originator) |
Biological Testing | Deuterated Compounds |
Autoimmune disease Cancer |
Sichuan Huiyu Pharmaceutical (Originator) Sichuan Huiyu Seacross Pharma Technology (Originator) |
Biological Testing | Deuterated Compounds |
Autoimmune disease Cancer |
Ranok Therapeutics (Hangzhou) (Originator) | Biological Testing | Deuterated Compounds | Cancer |
Livzon (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
Shanghai Leadingtac Pharmaceutical (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) |
Cancer Cardiofaciocutaneous syndrome Costello syndrome Neurofibromatosis type 1 Noonan syndrome |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Creative Biolabs is dedicated to supporting your scientific endeavors with premium research tools. Our anti-SOS1 recombinant antibody products demonstrate our dedication to innovation and excellence. To learn more about how these antibodies can accelerate your research or to discuss custom solutions, please do not hesitate to contact us directly.